Please confirm if you are a healthcare professional, or a patient or member of the public

I am a patient or member of the public

Cream

Lipid Stabilised Hydrogen Peroxide Cream 1%

photo of crystacide cream packaging

An alternative to topical antibiotics in the treatment of superficial primary and secondary skin infections, such as impetigo.

What is Crystacide cream used for?


Crystacide cream contains hydrogen peroxide 1%, a potent antibacterial agent with effect against Gram-positive as well as Gram-negative bacteria. It is intended for topical treatment of primary and secondary superficial skin infections caused by organisms sensitive to hydrogen peroxide, such as impetigo. Crystacide’s lipid-stabilised formulation has bactericidal activity equal to that of a 1% aqueous solution of hydrogen peroxide, and the duration of action is longer for the cream.⁴


Impetigo is a highly contagious disease, and the purpose of treatment is to clear the infection as quickly as possible to reduce the risk of spread of infection.



Hydrogen peroxide cream 1% is as effective as a topical antibiotic in the treatment of impetigo.¹

crystacide 40g tube crystacide 25g tube
Mum holding a smiling toddler and talking to a pharmacist. close up of face with impetigo infection

Recommended by NICE

NICE recommends a five-day course of hydrogen peroxide cream 1%, applied 2-3 times day as first-line treatment for localised, non-bullous impetigo in patients who are not systemically  unwell or at high risk of complications.¹

The NICE committee noted

“Impetigo is highly infectious, and the committee agreed that treatment is important to limit the spread of infection and the worsening of symptoms, and to hasten recovery. A faster recovery is also likely to mean less time off school, nursery or work.”

“The evidence suggested that hydrogen peroxide 1% cream (a topical antiseptic) is as effective as a topical antibiotic for treating impetigo. Impetigo was cured or improved in a large proportion of people using hydrogen peroxide.” 

“Based on the available evidence, the committee agreed that the long-term benefits of good antimicrobial stewardship, in combination with the low risk of adverse events compared with using a topical antibiotic, outweighed the additional cost of hydrogen peroxide 1% cream.”

shield with a checkmark

Available via Pharmacy First scheme

Community pharmacists are able to supply Crystacide cream for treatment of localised, non-bullous impetigo under the provisions of a Patient Group Direction.²

Crystacide is the first line treatment for this group of patients.

shield with a checkmark

Good antimicrobial stewardship

The rapid emergence of bacterial resistance is a common problem with antibiotic treatment for impetigo.³

A key benefit of using Crystacide, compared to antibiotics such as fusidic acid is that there are no known pathogenic bacteria or fungi that develop resistance to hydrogen peroxide.⁴

shield with a checkmark

Well
tolerated

The risks of adverse effects from hydrogen peroxide at 1% concentration, such as irritation and skin bleaching, are minimal.¹

Low risk of adverse events compared with using a topical antibiotic.¹

Useful resources

Information for patients
Professional resources
Medical Information and Adverse Events Reporting

Please note that Reig Jofre cannot answer any questions about your medical condition or give any health advice. If you have any concerns about a personal medical condition, please consult a healthcare professional.

To report a suspected adverse event to one of our products or to discuss a specific product enquiry either:
e: MedInfoUK@reigjofre.com
t: 0330 1359 434

Information on adverse event reporting to the UK Health Authority can be found at yellowcard.mhra.gov.uk

Crystacide cream is available in tubes of 25g and 40g

Crystacide - Summary of Product Characteristics

25g

40g

Crystacide - Patient Information Leaflet

25g

40g

References
  1. NICE. Impetigo: antimicrobial prescribing. NICE Guideline NG 153. February 2020. https://www.nice.org.uk/guidance/ng153.
  2. NHS England. Protocol for the supply of topical hydrogen peroxide 1% cream (e.g. Crystacide® 1% cream) for the treatment of localised non-bullous impetigo under the NHS England commissioned Pharmacy First service. Version number 1.0. 31.01.24.
  3. Schachner LA, Lynde CW, Kircik LH et al. Treatment of Impetigo and Antimicrobial Resistance. J Drugs Dermatol. 2021 Apr 1;20(4):366-372. doi: 10.36849/JDD.2021.5795. PMID: 33852242.
  4. Data on file Reig Jofre.
hand holding a tube of Crystacide cream